NCT02581137 2026-04-13
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
University of Kansas Medical Center
S.L.A. Pharma AG